COVID-19 and Vaccination Status in Lysosomal Storage Diseases: A Single-Center Experience

dc.authorscopusid58181536600
dc.authorscopusid23059712400
dc.authorscopusid57202984757
dc.authorscopusid58183170500
dc.authorscopusid57731091200
dc.authorscopusid35749318700
dc.authorscopusid26428601400
dc.contributor.authorYoldaş, Çelik, M.
dc.contributor.authorCanda, E.
dc.contributor.authorYazıcı, H.
dc.contributor.authorErdem, F.
dc.contributor.authorÖzkaya, P.Y.
dc.contributor.authorSahbudak, Z.B.
dc.contributor.authorUçar, S.K.
dc.date.accessioned2024-08-25T18:51:52Z
dc.date.available2024-08-25T18:51:52Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective: Coronavirus disease 2019 (COVID-19) causes significant morbidity and mortality in individuals with chronic disease. There is not enough information about the course of corona-virus disease in lysosomal storage diseases. This study aimed to evaluate coronavirus disease vaccination status and the impact of coronavirus disease on lysosomal storage disease. Materials and Methods: The study included 87 lysosomal storage disease patients. The patients’ diagnoses were Gaucher, mucopolysaccharidosis I, II, IVA, VI, VII, Fabry, and Pompe. A questionnaire assessing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, coronavirus disease symptoms, and vaccine status was administered in person or by phone calls. Results: The number of coronavirus disease positive patients was 8 (9.1%). Only 2 patients were treated in the intensive care unit. Other coronavirus disease patients had mild symptoms and stayed in-home quarantine. Patients over 12 years of age could receive a COVID-19 vaccine. 63.5% of those aged ?12 years were vaccinated. Conclusion: Lysosomal storage disease patients did not have an increased risk of COVID-19 compared to the healthy population, despite the chronic inflammatory disease. Vaccination of lysosomal storage disease patients will be protective against severe coronavirus disease. © 2023, AVES. All rights reserved.en_US
dc.identifier.doi10.5152/TurkArchPediatr.2023.22233
dc.identifier.endpage267en_US
dc.identifier.issn2757-6256
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85160523823en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage262en_US
dc.identifier.trdizinid1179221en_US
dc.identifier.urihttps://doi.org/10.5152/TurkArchPediatr.2023.22233
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1179221
dc.identifier.urihttps://hdl.handle.net/11454/102741
dc.identifier.volume58en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherAVESen_US
dc.relation.ispartofTurkish Archives of Pediatricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240825_Gen_US
dc.subjectCOVID-19en_US
dc.subjectfabryen_US
dc.subjectGaucheren_US
dc.subjectinherited metabolic diseasesen_US
dc.subjectlysosomal storage diseasesen_US
dc.subjectSARS-CoV-2en_US
dc.subjectcoronavacen_US
dc.subjectfavipiraviren_US
dc.subjectimmunoglobulinen_US
dc.subjectsteroiden_US
dc.subjecttenofoviren_US
dc.subjectadolescenten_US
dc.subjectadulten_US
dc.subjectanosmiaen_US
dc.subjectArticleen_US
dc.subjectchilden_US
dc.subjectclinical articleen_US
dc.subjectcoronavirus disease 2019en_US
dc.subjectdiabetes mellitusen_US
dc.subjectFabry diseaseen_US
dc.subjectfemaleen_US
dc.subjectGaucher diseaseen_US
dc.subjectheadacheen_US
dc.subjecthospitalizationen_US
dc.subjecthumanen_US
dc.subjecthypertensionen_US
dc.subjectinflammatory diseaseen_US
dc.subjectintensive care uniten_US
dc.subjectleukopeniaen_US
dc.subjectliver diseaseen_US
dc.subjectlung diseaseen_US
dc.subjectlysosome storage diseaseen_US
dc.subjectmaleen_US
dc.subjectmorbidityen_US
dc.subjectmortalityen_US
dc.subjectmucopolysaccharidosisen_US
dc.subjectnose smearen_US
dc.subjectobesityen_US
dc.subjectpneumoniaen_US
dc.subjectpolymerase chain reactionen_US
dc.subjectquestionnaireen_US
dc.subjectsore throaten_US
dc.subjectthrombocytopeniaen_US
dc.subjectvaccinationen_US
dc.titleCOVID-19 and Vaccination Status in Lysosomal Storage Diseases: A Single-Center Experienceen_US
dc.typeArticleen_US

Dosyalar